Pacemakers and implantable cardioverter defibrillators

Anaesthesia

Volumn 61, Issue 9, 2006, Pages 883-890

  Allen, M ^a  

^a MOORFIELDS EYE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; SOTALOL;

ANESTHESIST; BIOMEDICAL TECHNOLOGY ASSESSMENT; CARDIAC RESYNCHRONIZATION THERAPY; DEFIBRILLATOR; DIATHERMY; DISEASE SEVERITY; ELECTROMAGNETIC RADIATION; HEART FAILURE; HEART PACING; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; MAGNET; PACEMAKER; PATIENT MONITORING; PERIOPERATIVE PERIOD; PEROPERATIVE CARE; POSTOPERATIVE CARE; PRACTICE GUIDELINE; PREOPERATIVE EVALUATION; REVIEW; RISK ASSESSMENT; SUDDEN DEATH; SURGICAL TECHNIQUE; TACHYCARDIA; UNITED KINGDOM;

DEFIBRILLATORS, IMPLANTABLE; ELECTROMAGNETIC FIELDS; EQUIPMENT DESIGN; HUMANS; PACEMAKER, ARTIFICIAL; PERIOPERATIVE CARE;

EID: 33747126408     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/j.1365-2044.2006.04722.x     Document Type: Review

References (22)

1. Cunningham AD. 2004 Report for European Heart Rhythm Association. Central Cardiac Audit Database. November 2005.
2. Gammage M. Treatment with pacemakers. Arrhythmia Alliance Resource Book, 5th edn. Stratford-upon-Avon: Arrhythmia Alliance, 2004; 12, 107-28.
3. Connolly SJ, Hallstrom AP, Cappato R, et al. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. European Heart Journal 2000; 21: 2071-8.
4. National Institute for Clinical Excellence. Guidance On the Use of Implantable Cardioverter Defibrillators for Arrhythmias. Technology Appraisal Guidance 11. NICE, 2006.
5. Lamas GA, Lee KL, Sweeny MO, et al. Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. New England Journal of Medicine 2002; 346: 1854-62.
6. Kerr CR, Connolly SJ, Abdollah H, et al. Canadian Trial of Physiological Pacing: Effects of physiological pacing during long-term follow-up. Circulation 2004; 109: 357-62.
7. Toff WD, Skehan JD, De Bono DP, et al. The United Kingdom pacing and cardiovascular events (UKPACE) trial. Heart 1997; 78: 221-3.
8. Bernstein AD, Camm AJ, Fletcher RD, et al. The NASPE/BPEG generic pacemaker code for antibradyarrhythmia and adaptive-rate pacing and antitachyarrhythmia devices. Pacing and Clinical Electrophysiology 1987; 10: 794-9.
9. Bernstein AD, Daubert JC, Fletcher RD, et al. The revised NASPE/BPEG generic code for antibradycardia, adaptive-rate, and multisite pacing. Pacing and Clinical Electrophysiology 2002; 25: 260-4.
10. Sutton Royal, Kenny RA. The natural history of sick sinus syndrome. Pacing and Clinical Electrophysiology 1986; 9: 1110-4.
11. Salukhe TV, Dob D, Sutton R. Pacemakers and defibrillators: Anaesthetic implications. British Journal of Anaesthesia 2004; 93: 95-104.
12. Connelly DT. Implantable cardioverter defibrillators. Heart 2001; 86: 221-6.
13. Mirowski M, Reid PR, Mower MM, et al. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. New England Journal of Medicine 1980; 303: 322-4.
14. Bernstein AD, Camm AJ, Fisher JD, et al. North American Society of Pacing and Electrophysiology policy statement. The NASPE/BPEG defibrillator code. Pacing and Clinical Electrophysiology 1993; 16: 1776-80.
15. Luechinger R, Zeijlemaker VA, Pedersen EM, et al. In vivo heating of pacemaker leads during magnetic resonance imaging. European Heart Journal 2005; 26: 376-83.
16. American Society of Anesthesiologists Task Force on Perioperative Management of Patients with Cardiac Rhythm Management Devices. Practice advisory for the perioperative management of patients with cardiac rhythm management devices. Anesthesiology 2005; 103: 186-98.
17. Ahern TS, Luckett C, Ehrlich S, Pena EA. Use of bipolar electrocautery in patients with implantable cardioverter defibrillators: No reason to inactivate detection or therapies. Pacing and Clinical Electrophysiology 1999; 22: 778.
18. Chew EW, Troughear RH, Kuchar DL, Thorburn CW. Inappropriate rate change in minute ventilation rate responsive pacemakers due to interference by cardiac monitors. Pacing and Clinical Electrophysiology 1997; 20: 276-82.
19. Houtman S, Rinia M, Kalkman C. Monitor-induced tachycardia in a patient with a rate-responsive pacemaker. Anaesthesia 2006; 61: 399-401.
20. Wallden J, Gupta A, Carlsen HO. Supraventricular tachycardia induced by Datex patient monitoring system. Anesthesia and Analgesia 1998; 86: 1339.
21. Gould L, Patel S, Gomes GI, Chokshi AB. Pacemaker failure following external defibrillation. Pacing and Clinical Electrophysiology 1981; 4: 575-7.
22. Medicines and Healthcare Products Regulatory Agency. Guidelines for the Perioperative Management of Patients with Implantable Pacemakers or Implantable Cardioverter Defibrillators, Where the Use of Surgical Diathermy/Electrocautery Is Anticipated, March 2006. London: Medicines and Healthcare Products Regulatory Agency, 2006.